Features of metabolic atypism during the development of oncological pathology of the urogenital system


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Urological and genital malignant neoplasms in men are an urgent problem. Every year, about 403.3 thousand newly diagnosed cases of kidney cancer and 34.5 thousand of penile cancer are registered in the world. With metabolic atypism, a change in all its components is observed, tumor cells trap the most important substrates and metabolites. The aim of the study. Study of the content of bioelements in certain types of cancer of the genitourinary system using innovative research methods. Methods. Patients with kidney and penile cancer were identified. For scanning electron microscopy, samples were taken without fixation, studied in an FE1 Quanta 600 FEG scanning microscope integrated with a detector for recording characteristic X-ray spectra from EPAX. Results. Along with tumor growth in the kidneys, the content of oxygen, magnesium, and calcium increases by 1.36, 2.45 and 2 times, respectively, and the content of sodium and potassium decreases by 1.2 and 5.25 times. In regional lymph nodes, the content of sodium increases by 1.2 times and phosphorus by 2.2 times, and oxygen, magnesium, potassium, and calcium decreases by 1.3, 2.2, 7.5, and 3.6 times respectively. In regional lymph nodes, the content of sodium increases by 1.2 times and phosphorus by 2.2 times, and oxygen, magnesium, potassium, and calcium decreases by 1.3, 2.2, 7.5, and 3.6 times respectively. Conclusion. With tumor growth in the kidneys, the content of oxygen, magnesium, calcium, and phosphorus increases, while the content of both sodium and potassium decreases. In the regional lymph nodes, the content of sodium and phosphorus increases, and there is a decrease in oxygen, magnesium, potassium, and calcium. In tumor growth in the penis, the content of oxygen, sodium, magnesium, phosphorus, calcium increases.

Full Text

Restricted Access

About the authors

Tatiana Vasilievna Pavlova

Belgorod State University

Email: pavlova@bsu.edu.ru
Head of the Department of Pathology, Medical Institute

Natalia Borisovna Pilkevich

Belgorod State University

Email: pilkevich@bsu.edu.ru
Professor of the Department of Pathology, Medical Institute

Dmitry Vasilievich Bessmertnyy

Belgorod Regional Oncological Dispensary

Email: bes-2010@mail.ru
Oncourologist

Ivan Arnoldovich Pavlov

Belgorod Regional Oncological Dispensary

Email: pavlov-belgorod@mail.ru
Oncourologist

References

  1. Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР Онкоурология. 2019; 15 (2): 15-24
  2. Состояние онкологической помощи населению России в 2017 году Под ред. А.Д. Каприна, В.В. Старинского, ГВ. Петровой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2018; 236
  3. Жуковская Е.В. Метаболический синдром у пациентов с онкологическими заболеваниями (обзор литературы). Педиатрический вестник Южного Урала. 2016; 1: 62-6
  4. Скальный А.В., Рудаков И.А. Биоэлементы в медицине. Оникс 21 век, Мир. 2004; 272
  5. Brierley J.D. et al. TNM Classification of Malignant Tumours, 8th еd. International Union Against Cancer, Wiley-Blackwell. 2016; 188-9
  6. Hakenberg O.W., Comperat E., Minhas S., Necchi A., Protzel C., Watkin N. Guidelines on Penile Cancer. EAU. Pizzocaro G., Algaba F., Solsona E. et al. Guidelines. 2017; 20-1
  7. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat Rev Cancer, 2011; 11 (2): 85-95. doi: 10.1038/nrc2981
  8. Pavlova T.V., Pavlov I.A., Pilkevich N.B., Chaplyginа M.A. New approachesin the diagnosis of kidney cancer. Drug Inven-tionToday end of September. 2019; 12 (9): 2094-9

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies